Ardent Health (NYSE:ARDT) Announces Earnings Results

Ardent Health (NYSE:ARDT) announced its quarterly earnings data on Tuesday. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06), FiscalAI reports. The company had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. Ardent Health updated its FY 2026 guidance to 0.780-1.150 EPS.

Ardent Health Trading Up 0.4%

Ardent Health stock traded up $0.04 during trading on Wednesday, hitting $10.79. The company’s stock had a trading volume of 96,268 shares, compared to its average volume of 458,841. The stock’s fifty day moving average is $9.86 and its 200 day moving average is $9.44. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.00 and a current ratio of 2.12. Ardent Health has a 1-year low of $7.71 and a 1-year high of $15.48. The stock has a market capitalization of $1.55 billion, a price-to-earnings ratio of 11.36, a P/E/G ratio of 2.53 and a beta of 0.70.

Insiders Place Their Bets

In other news, CFO Alfred Lumsdaine acquired 10,000 shares of the stock in a transaction on Friday, June 5th. The stock was bought at an average price of $8.81 per share, with a total value of $88,100.00. Following the completion of the transaction, the chief financial officer directly owned 329,183 shares of the company’s stock, valued at $2,900,102.23. The trade was a 3.13% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.90% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Ardent Health by 103.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock valued at $194,000 after purchasing an additional 7,182 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after purchasing an additional 724,841 shares during the period. Jane Street Group LLC grew its position in Ardent Health by 235.1% in the 1st quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock worth $790,000 after purchasing an additional 40,318 shares during the last quarter. Acadian Asset Management LLC increased its stake in shares of Ardent Health by 574.9% in the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock valued at $550,000 after purchasing an additional 34,276 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Ardent Health by 0.6% in the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,769 shares during the period.

Analyst Ratings Changes

A number of analysts recently weighed in on ARDT shares. Truist Financial decreased their price target on shares of Ardent Health from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Tuesday, July 14th. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Ardent Health in a research note on Friday, June 12th. UBS Group increased their price objective on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Finally, Royal Bank Of Canada lowered their target price on Ardent Health from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Thursday, July 9th. Seven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Ardent Health presently has an average rating of “Hold” and a consensus price target of $14.04.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.